 | • レポートコード：GIR-23F3819 • 出版社/出版日：GlobalInfoResearch / 2023年2月 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Hemorrhagic Septicemia Vaccines Market」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社（香港）の最新の調査によると、世界の出血性敗血症ワクチンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 出血性敗血症ワクチン市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次を対象にします。 ・オイルアジュバントワクチン、水酸化アルミニウムアジュバントワクチン アプリケーション別セグメントは次のように区分されます。 ・牛、水牛 世界の出血性敗血症ワクチン市場の主要なマーケットプレーヤーは以下のとおりです。 ・Bio-Labs (PVT) Limited、Brilliant Bio Pharma、C.A. Laboratorios Asociados (CALA)、Ceva Santé Animale、Vecol、FATRO、Indian Immunologicals Limited、Institute of Animal Health and Veterinary Biologicals、Institute of Veterinary Preventive Medicine、Intervac (PVT) Ltd、LABIOFAM、Laboratorios Laverlam、Laboratorios Ovejero、Limor de Colombia、National Veterinary Research Institute、Zoetis 地域別セグメントは次の地域・国を対象にします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） ***** 目次(一部) ***** ・市場概要 - 出血性敗血症ワクチンの概要 - タイプ別分析（2017年vs2021年vs2028年）：オイルアジュバントワクチン、水酸化アルミニウムアジュバントワクチン - アプリケーション別分析（2017年vs2021年vs2028年）：牛、水牛 - 世界の出血性敗血症ワクチン市場規模・予測 - 世界の出血性敗血症ワクチン生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Bio-Labs (PVT) Limited、Brilliant Bio Pharma、C.A. Laboratorios Asociados (CALA)、Ceva Santé Animale、Vecol、FATRO、Indian Immunologicals Limited、Institute of Animal Health and Veterinary Biologicals、Institute of Veterinary Preventive Medicine、Intervac (PVT) Ltd、LABIOFAM、Laboratorios Laverlam、Laboratorios Ovejero、Limor de Colombia、National Veterinary Research Institute、Zoetis ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：オイルアジュバントワクチン、水酸化アルミニウムアジュバントワクチン ・アプリケーション別分析2017年-2028年：牛、水牛 ・出血性敗血症ワクチンの北米市場分析 - 出血性敗血症ワクチンの北米市場：タイプ別市場規模2017年-2028年 - 出血性敗血症ワクチンの北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・出血性敗血症ワクチンのヨーロッパ市場分析 - ：出血性敗血症ワクチンのヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：出血性敗血症ワクチンのヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・出血性敗血症ワクチンのアジア太平洋市場分析 - 出血性敗血症ワクチンのアジア太平洋市場：タイプ別市場規模2017年-2028年 - 出血性敗血症ワクチンのアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・出血性敗血症ワクチンの南米市場分析 - 出血性敗血症ワクチンの南米市場：タイプ別市場規模2017年-2028年 - 出血性敗血症ワクチンの南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・出血性敗血症ワクチンの中東・アフリカ市場分析 - 出血性敗血症ワクチンの中東・アフリカ市場：タイプ別市場規模2017年-2028年 - 出血性敗血症ワクチンの中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Hemorrhagic Septicemia Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Hemorrhagic Septicemia Vaccines market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Cattle accounting for % of the Hemorrhagic Septicemia Vaccines global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Oil–adjuvant Vaccines segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Hemorrhagic Septicemia Vaccines include Bio-Labs (PVT) Limited, Brilliant Bio Pharma, C.A. Laboratorios Asociados (CALA), Ceva Santé Animale, and Vecol, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Hemorrhagic Septicemia Vaccines market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Oil–adjuvant Vaccines
Aluminum hydroxide-adjuvant Vaccines
Market segment by Application can be divided into
Cattle
Buffaloes
The key market players for global Hemorrhagic Septicemia Vaccines market are listed below:
Bio-Labs (PVT) Limited
Brilliant Bio Pharma
C.A. Laboratorios Asociados (CALA)
Ceva Santé Animale
Vecol
FATRO
Indian Immunologicals Limited
Institute of Animal Health and Veterinary Biologicals
Institute of Veterinary Preventive Medicine
Intervac (PVT) Ltd
LABIOFAM
Laboratorios Laverlam
Laboratorios Ovejero
Limor de Colombia
National Veterinary Research Institute
Zoetis
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Hemorrhagic Septicemia Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Hemorrhagic Septicemia Vaccines, with price, sales, revenue and global market share of Hemorrhagic Septicemia Vaccines from 2019 to 2022.
Chapter 3, the Hemorrhagic Septicemia Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Hemorrhagic Septicemia Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Hemorrhagic Septicemia Vaccines market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Hemorrhagic Septicemia Vaccines.
Chapter 13, 14, and 15, to describe Hemorrhagic Septicemia Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Hemorrhagic Septicemia Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Hemorrhagic Septicemia Vaccines Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Oil–adjuvant Vaccines
1.2.3 Aluminum hydroxide-adjuvant Vaccines
1.3 Market Analysis by Application
1.3.1 Overview: Global Hemorrhagic Septicemia Vaccines Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Cattle
1.3.3 Buffaloes
1.4 Global Hemorrhagic Septicemia Vaccines Market Size & Forecast
1.4.1 Global Hemorrhagic Septicemia Vaccines Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Hemorrhagic Septicemia Vaccines Sales in Volume (2017-2028)
1.4.3 Global Hemorrhagic Septicemia Vaccines Price (2017-2028)
1.5 Global Hemorrhagic Septicemia Vaccines Production Capacity Analysis
1.5.1 Global Hemorrhagic Septicemia Vaccines Total Production Capacity (2017-2028)
1.5.2 Global Hemorrhagic Septicemia Vaccines Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Hemorrhagic Septicemia Vaccines Market Drivers
1.6.2 Hemorrhagic Septicemia Vaccines Market Restraints
1.6.3 Hemorrhagic Septicemia Vaccines Trends Analysis
2 Manufacturers Profiles
2.1 Bio-Labs (PVT) Limited
2.1.1 Bio-Labs (PVT) Limited Details
2.1.2 Bio-Labs (PVT) Limited Major Business
2.1.3 Bio-Labs (PVT) Limited Hemorrhagic Septicemia Vaccines Product and Services
2.1.4 Bio-Labs (PVT) Limited Hemorrhagic Septicemia Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Brilliant Bio Pharma
2.2.1 Brilliant Bio Pharma Details
2.2.2 Brilliant Bio Pharma Major Business
2.2.3 Brilliant Bio Pharma Hemorrhagic Septicemia Vaccines Product and Services
2.2.4 Brilliant Bio Pharma Hemorrhagic Septicemia Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 C.A. Laboratorios Asociados (CALA)
2.3.1 C.A. Laboratorios Asociados (CALA) Details
2.3.2 C.A. Laboratorios Asociados (CALA) Major Business
2.3.3 C.A. Laboratorios Asociados (CALA) Hemorrhagic Septicemia Vaccines Product and Services
2.3.4 C.A. Laboratorios Asociados (CALA) Hemorrhagic Septicemia Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Ceva Santé Animale
2.4.1 Ceva Santé Animale Details
2.4.2 Ceva Santé Animale Major Business
2.4.3 Ceva Santé Animale Hemorrhagic Septicemia Vaccines Product and Services
2.4.4 Ceva Santé Animale Hemorrhagic Septicemia Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Vecol
2.5.1 Vecol Details
2.5.2 Vecol Major Business
2.5.3 Vecol Hemorrhagic Septicemia Vaccines Product and Services
2.5.4 Vecol Hemorrhagic Septicemia Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 FATRO
2.6.1 FATRO Details
2.6.2 FATRO Major Business
2.6.3 FATRO Hemorrhagic Septicemia Vaccines Product and Services
2.6.4 FATRO Hemorrhagic Septicemia Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Indian Immunologicals Limited
2.7.1 Indian Immunologicals Limited Details
2.7.2 Indian Immunologicals Limited Major Business
2.7.3 Indian Immunologicals Limited Hemorrhagic Septicemia Vaccines Product and Services
2.7.4 Indian Immunologicals Limited Hemorrhagic Septicemia Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Institute of Animal Health and Veterinary Biologicals
2.8.1 Institute of Animal Health and Veterinary Biologicals Details
2.8.2 Institute of Animal Health and Veterinary Biologicals Major Business
2.8.3 Institute of Animal Health and Veterinary Biologicals Hemorrhagic Septicemia Vaccines Product and Services
2.8.4 Institute of Animal Health and Veterinary Biologicals Hemorrhagic Septicemia Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Institute of Veterinary Preventive Medicine
2.9.1 Institute of Veterinary Preventive Medicine Details
2.9.2 Institute of Veterinary Preventive Medicine Major Business
2.9.3 Institute of Veterinary Preventive Medicine Hemorrhagic Septicemia Vaccines Product and Services
2.9.4 Institute of Veterinary Preventive Medicine Hemorrhagic Septicemia Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Intervac (PVT) Ltd
2.10.1 Intervac (PVT) Ltd Details
2.10.2 Intervac (PVT) Ltd Major Business
2.10.3 Intervac (PVT) Ltd Hemorrhagic Septicemia Vaccines Product and Services
2.10.4 Intervac (PVT) Ltd Hemorrhagic Septicemia Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 LABIOFAM
2.11.1 LABIOFAM Details
2.11.2 LABIOFAM Major Business
2.11.3 LABIOFAM Hemorrhagic Septicemia Vaccines Product and Services
2.11.4 LABIOFAM Hemorrhagic Septicemia Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Laboratorios Laverlam
2.12.1 Laboratorios Laverlam Details
2.12.2 Laboratorios Laverlam Major Business
2.12.3 Laboratorios Laverlam Hemorrhagic Septicemia Vaccines Product and Services
2.12.4 Laboratorios Laverlam Hemorrhagic Septicemia Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Laboratorios Ovejero
2.13.1 Laboratorios Ovejero Details
2.13.2 Laboratorios Ovejero Major Business
2.13.3 Laboratorios Ovejero Hemorrhagic Septicemia Vaccines Product and Services
2.13.4 Laboratorios Ovejero Hemorrhagic Septicemia Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Limor de Colombia
2.14.1 Limor de Colombia Details
2.14.2 Limor de Colombia Major Business
2.14.3 Limor de Colombia Hemorrhagic Septicemia Vaccines Product and Services
2.14.4 Limor de Colombia Hemorrhagic Septicemia Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 National Veterinary Research Institute
2.15.1 National Veterinary Research Institute Details
2.15.2 National Veterinary Research Institute Major Business
2.15.3 National Veterinary Research Institute Hemorrhagic Septicemia Vaccines Product and Services
2.15.4 National Veterinary Research Institute Hemorrhagic Septicemia Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Zoetis
2.16.1 Zoetis Details
2.16.2 Zoetis Major Business
2.16.3 Zoetis Hemorrhagic Septicemia Vaccines Product and Services
2.16.4 Zoetis Hemorrhagic Septicemia Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Hemorrhagic Septicemia Vaccines Breakdown Data by Manufacturer
3.1 Global Hemorrhagic Septicemia Vaccines Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Hemorrhagic Septicemia Vaccines Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Hemorrhagic Septicemia Vaccines
3.4 Market Concentration Rate
3.4.1 Top 3 Hemorrhagic Septicemia Vaccines Manufacturer Market Share in 2021
3.4.2 Top 6 Hemorrhagic Septicemia Vaccines Manufacturer Market Share in 2021
3.5 Global Hemorrhagic Septicemia Vaccines Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Hemorrhagic Septicemia Vaccines Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Hemorrhagic Septicemia Vaccines Market Size by Region
4.1.1 Global Hemorrhagic Septicemia Vaccines Sales in Volume by Region (2017-2028)
4.1.2 Global Hemorrhagic Septicemia Vaccines Revenue by Region (2017-2028)
4.2 North America Hemorrhagic Septicemia Vaccines Revenue (2017-2028)
4.3 Europe Hemorrhagic Septicemia Vaccines Revenue (2017-2028)
4.4 Asia-Pacific Hemorrhagic Septicemia Vaccines Revenue (2017-2028)
4.5 South America Hemorrhagic Septicemia Vaccines Revenue (2017-2028)
4.6 Middle East and Africa Hemorrhagic Septicemia Vaccines Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Hemorrhagic Septicemia Vaccines Sales in Volume by Type (2017-2028)
5.2 Global Hemorrhagic Septicemia Vaccines Revenue by Type (2017-2028)
5.3 Global Hemorrhagic Septicemia Vaccines Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Hemorrhagic Septicemia Vaccines Sales in Volume by Application (2017-2028)
6.2 Global Hemorrhagic Septicemia Vaccines Revenue by Application (2017-2028)
6.3 Global Hemorrhagic Septicemia Vaccines Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Hemorrhagic Septicemia Vaccines Sales by Type (2017-2028)
7.2 North America Hemorrhagic Septicemia Vaccines Sales by Application (2017-2028)
7.3 North America Hemorrhagic Septicemia Vaccines Market Size by Country
7.3.1 North America Hemorrhagic Septicemia Vaccines Sales in Volume by Country (2017-2028)
7.3.2 North America Hemorrhagic Septicemia Vaccines Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Hemorrhagic Septicemia Vaccines Sales by Type (2017-2028)
8.2 Europe Hemorrhagic Septicemia Vaccines Sales by Application (2017-2028)
8.3 Europe Hemorrhagic Septicemia Vaccines Market Size by Country
8.3.1 Europe Hemorrhagic Septicemia Vaccines Sales in Volume by Country (2017-2028)
8.3.2 Europe Hemorrhagic Septicemia Vaccines Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Hemorrhagic Septicemia Vaccines Sales by Type (2017-2028)
9.2 Asia-Pacific Hemorrhagic Septicemia Vaccines Sales by Application (2017-2028)
9.3 Asia-Pacific Hemorrhagic Septicemia Vaccines Market Size by Region
9.3.1 Asia-Pacific Hemorrhagic Septicemia Vaccines Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Hemorrhagic Septicemia Vaccines Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Hemorrhagic Septicemia Vaccines Sales by Type (2017-2028)
10.2 South America Hemorrhagic Septicemia Vaccines Sales by Application (2017-2028)
10.3 South America Hemorrhagic Septicemia Vaccines Market Size by Country
10.3.1 South America Hemorrhagic Septicemia Vaccines Sales in Volume by Country (2017-2028)
10.3.2 South America Hemorrhagic Septicemia Vaccines Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Hemorrhagic Septicemia Vaccines Sales by Type (2017-2028)
11.2 Middle East & Africa Hemorrhagic Septicemia Vaccines Sales by Application (2017-2028)
11.3 Middle East & Africa Hemorrhagic Septicemia Vaccines Market Size by Country
11.3.1 Middle East & Africa Hemorrhagic Septicemia Vaccines Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Hemorrhagic Septicemia Vaccines Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Hemorrhagic Septicemia Vaccines and Key Manufacturers
12.2 Manufacturing Costs Percentage of Hemorrhagic Septicemia Vaccines
12.3 Hemorrhagic Septicemia Vaccines Production Process
12.4 Hemorrhagic Septicemia Vaccines Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Hemorrhagic Septicemia Vaccines Typical Distributors
13.3 Hemorrhagic Septicemia Vaccines Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
Table 1. Global Hemorrhagic Septicemia Vaccines Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Hemorrhagic Septicemia Vaccines Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Bio-Labs (PVT) Limited Basic Information, Manufacturing Base and Competitors
Table 4. Bio-Labs (PVT) Limited Major Business
Table 5. Bio-Labs (PVT) Limited Hemorrhagic Septicemia Vaccines Product and Services
Table 6. Bio-Labs (PVT) Limited Hemorrhagic Septicemia Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Brilliant Bio Pharma Basic Information, Manufacturing Base and Competitors
Table 8. Brilliant Bio Pharma Major Business
Table 9. Brilliant Bio Pharma Hemorrhagic Septicemia Vaccines Product and Services
Table 10. Brilliant Bio Pharma Hemorrhagic Septicemia Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. C.A. Laboratorios Asociados (CALA) Basic Information, Manufacturing Base and Competitors
Table 12. C.A. Laboratorios Asociados (CALA) Major Business
Table 13. C.A. Laboratorios Asociados (CALA) Hemorrhagic Septicemia Vaccines Product and Services
Table 14. C.A. Laboratorios Asociados (CALA) Hemorrhagic Septicemia Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Ceva Santé Animale Basic Information, Manufacturing Base and Competitors
Table 16. Ceva Santé Animale Major Business
Table 17. Ceva Santé Animale Hemorrhagic Septicemia Vaccines Product and Services
Table 18. Ceva Santé Animale Hemorrhagic Septicemia Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Vecol Basic Information, Manufacturing Base and Competitors
Table 20. Vecol Major Business
Table 21. Vecol Hemorrhagic Septicemia Vaccines Product and Services
Table 22. Vecol Hemorrhagic Septicemia Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. FATRO Basic Information, Manufacturing Base and Competitors
Table 24. FATRO Major Business
Table 25. FATRO Hemorrhagic Septicemia Vaccines Product and Services
Table 26. FATRO Hemorrhagic Septicemia Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Indian Immunologicals Limited Basic Information, Manufacturing Base and Competitors
Table 28. Indian Immunologicals Limited Major Business
Table 29. Indian Immunologicals Limited Hemorrhagic Septicemia Vaccines Product and Services
Table 30. Indian Immunologicals Limited Hemorrhagic Septicemia Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Institute of Animal Health and Veterinary Biologicals Basic Information, Manufacturing Base and Competitors
Table 32. Institute of Animal Health and Veterinary Biologicals Major Business
Table 33. Institute of Animal Health and Veterinary Biologicals Hemorrhagic Septicemia Vaccines Product and Services
Table 34. Institute of Animal Health and Veterinary Biologicals Hemorrhagic Septicemia Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Institute of Veterinary Preventive Medicine Basic Information, Manufacturing Base and Competitors
Table 36. Institute of Veterinary Preventive Medicine Major Business
Table 37. Institute of Veterinary Preventive Medicine Hemorrhagic Septicemia Vaccines Product and Services
Table 38. Institute of Veterinary Preventive Medicine Hemorrhagic Septicemia Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Intervac (PVT) Ltd Basic Information, Manufacturing Base and Competitors
Table 40. Intervac (PVT) Ltd Major Business
Table 41. Intervac (PVT) Ltd Hemorrhagic Septicemia Vaccines Product and Services
Table 42. Intervac (PVT) Ltd Hemorrhagic Septicemia Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. LABIOFAM Basic Information, Manufacturing Base and Competitors
Table 44. LABIOFAM Major Business
Table 45. LABIOFAM Hemorrhagic Septicemia Vaccines Product and Services
Table 46. LABIOFAM Hemorrhagic Septicemia Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Laboratorios Laverlam Basic Information, Manufacturing Base and Competitors
Table 48. Laboratorios Laverlam Major Business
Table 49. Laboratorios Laverlam Hemorrhagic Septicemia Vaccines Product and Services
Table 50. Laboratorios Laverlam Hemorrhagic Septicemia Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Laboratorios Ovejero Basic Information, Manufacturing Base and Competitors
Table 52. Laboratorios Ovejero Major Business
Table 53. Laboratorios Ovejero Hemorrhagic Septicemia Vaccines Product and Services
Table 54. Laboratorios Ovejero Hemorrhagic Septicemia Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Limor de Colombia Basic Information, Manufacturing Base and Competitors
Table 56. Limor de Colombia Major Business
Table 57. Limor de Colombia Hemorrhagic Septicemia Vaccines Product and Services
Table 58. Limor de Colombia Hemorrhagic Septicemia Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. National Veterinary Research Institute Basic Information, Manufacturing Base and Competitors
Table 60. National Veterinary Research Institute Major Business
Table 61. National Veterinary Research Institute Hemorrhagic Septicemia Vaccines Product and Services
Table 62. National Veterinary Research Institute Hemorrhagic Septicemia Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Zoetis Basic Information, Manufacturing Base and Competitors
Table 64. Zoetis Major Business
Table 65. Zoetis Hemorrhagic Septicemia Vaccines Product and Services
Table 66. Zoetis Hemorrhagic Septicemia Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Global Hemorrhagic Septicemia Vaccines Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 68. Global Hemorrhagic Septicemia Vaccines Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 69. Market Position of Manufacturers in Hemorrhagic Septicemia Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 70. Global Hemorrhagic Septicemia Vaccines Production Capacity by Company, (K Units): 2020 VS 2021
Table 71. Head Office and Hemorrhagic Septicemia Vaccines Production Site of Key Manufacturer
Table 72. Hemorrhagic Septicemia Vaccines New Entrant and Capacity Expansion Plans
Table 73. Hemorrhagic Septicemia Vaccines Mergers & Acquisitions in the Past Five Years
Table 74. Global Hemorrhagic Septicemia Vaccines Sales by Region (2017-2022) & (K Units)
Table 75. Global Hemorrhagic Septicemia Vaccines Sales by Region (2023-2028) & (K Units)
Table 76. Global Hemorrhagic Septicemia Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 77. Global Hemorrhagic Septicemia Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 78. Global Hemorrhagic Septicemia Vaccines Sales by Type (2017-2022) & (K Units)
Table 79. Global Hemorrhagic Septicemia Vaccines Sales by Type (2023-2028) & (K Units)
Table 80. Global Hemorrhagic Septicemia Vaccines Revenue by Type (2017-2022) & (USD Million)
Table 81. Global Hemorrhagic Septicemia Vaccines Revenue by Type (2023-2028) & (USD Million)
Table 82. Global Hemorrhagic Septicemia Vaccines Price by Type (2017-2022) & (USD/Unit)
Table 83. Global Hemorrhagic Septicemia Vaccines Price by Type (2023-2028) & (USD/Unit)
Table 84. Global Hemorrhagic Septicemia Vaccines Sales by Application (2017-2022) & (K Units)
Table 85. Global Hemorrhagic Septicemia Vaccines Sales by Application (2023-2028) & (K Units)
Table 86. Global Hemorrhagic Septicemia Vaccines Revenue by Application (2017-2022) & (USD Million)
Table 87. Global Hemorrhagic Septicemia Vaccines Revenue by Application (2023-2028) & (USD Million)
Table 88. Global Hemorrhagic Septicemia Vaccines Price by Application (2017-2022) & (USD/Unit)
Table 89. Global Hemorrhagic Septicemia Vaccines Price by Application (2023-2028) & (USD/Unit)
Table 90. North America Hemorrhagic Septicemia Vaccines Sales by Country (2017-2022) & (K Units)
Table 91. North America Hemorrhagic Septicemia Vaccines Sales by Country (2023-2028) & (K Units)
Table 92. North America Hemorrhagic Septicemia Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 93. North America Hemorrhagic Septicemia Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 94. North America Hemorrhagic Septicemia Vaccines Sales by Type (2017-2022) & (K Units)
Table 95. North America Hemorrhagic Septicemia Vaccines Sales by Type (2023-2028) & (K Units)
Table 96. North America Hemorrhagic Septicemia Vaccines Sales by Application (2017-2022) & (K Units)
Table 97. North America Hemorrhagic Septicemia Vaccines Sales by Application (2023-2028) & (K Units)
Table 98. Europe Hemorrhagic Septicemia Vaccines Sales by Country (2017-2022) & (K Units)
Table 99. Europe Hemorrhagic Septicemia Vaccines Sales by Country (2023-2028) & (K Units)
Table 100. Europe Hemorrhagic Septicemia Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 101. Europe Hemorrhagic Septicemia Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 102. Europe Hemorrhagic Septicemia Vaccines Sales by Type (2017-2022) & (K Units)
Table 103. Europe Hemorrhagic Septicemia Vaccines Sales by Type (2023-2028) & (K Units)
Table 104. Europe Hemorrhagic Septicemia Vaccines Sales by Application (2017-2022) & (K Units)
Table 105. Europe Hemorrhagic Septicemia Vaccines Sales by Application (2023-2028) & (K Units)
Table 106. Asia-Pacific Hemorrhagic Septicemia Vaccines Sales by Region (2017-2022) & (K Units)
Table 107. Asia-Pacific Hemorrhagic Septicemia Vaccines Sales by Region (2023-2028) & (K Units)
Table 108. Asia-Pacific Hemorrhagic Septicemia Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 109. Asia-Pacific Hemorrhagic Septicemia Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 110. Asia-Pacific Hemorrhagic Septicemia Vaccines Sales by Type (2017-2022) & (K Units)
Table 111. Asia-Pacific Hemorrhagic Septicemia Vaccines Sales by Type (2023-2028) & (K Units)
Table 112. Asia-Pacific Hemorrhagic Septicemia Vaccines Sales by Application (2017-2022) & (K Units)
Table 113. Asia-Pacific Hemorrhagic Septicemia Vaccines Sales by Application (2023-2028) & (K Units)
Table 114. South America Hemorrhagic Septicemia Vaccines Sales by Country (2017-2022) & (K Units)
Table 115. South America Hemorrhagic Septicemia Vaccines Sales by Country (2023-2028) & (K Units)
Table 116. South America Hemorrhagic Septicemia Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 117. South America Hemorrhagic Septicemia Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 118. South America Hemorrhagic Septicemia Vaccines Sales by Type (2017-2022) & (K Units)
Table 119. South America Hemorrhagic Septicemia Vaccines Sales by Type (2023-2028) & (K Units)
Table 120. South America Hemorrhagic Septicemia Vaccines Sales by Application (2017-2022) & (K Units)
Table 121. South America Hemorrhagic Septicemia Vaccines Sales by Application (2023-2028) & (K Units)
Table 122. Middle East & Africa Hemorrhagic Septicemia Vaccines Sales by Region (2017-2022) & (K Units)
Table 123. Middle East & Africa Hemorrhagic Septicemia Vaccines Sales by Region (2023-2028) & (K Units)
Table 124. Middle East & Africa Hemorrhagic Septicemia Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 125. Middle East & Africa Hemorrhagic Septicemia Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 126. Middle East & Africa Hemorrhagic Septicemia Vaccines Sales by Type (2017-2022) & (K Units)
Table 127. Middle East & Africa Hemorrhagic Septicemia Vaccines Sales by Type (2023-2028) & (K Units)
Table 128. Middle East & Africa Hemorrhagic Septicemia Vaccines Sales by Application (2017-2022) & (K Units)
Table 129. Middle East & Africa Hemorrhagic Septicemia Vaccines Sales by Application (2023-2028) & (K Units)
Table 130. Hemorrhagic Septicemia Vaccines Raw Material
Table 131. Key Manufacturers of Hemorrhagic Septicemia Vaccines Raw Materials
Table 132. Direct Channel Pros & Cons
Table 133. Indirect Channel Pros & Cons
Table 134. Hemorrhagic Septicemia Vaccines Typical Distributors
Table 135. Hemorrhagic Septicemia Vaccines Typical Customers
List of Figures
Figure 1. Hemorrhagic Septicemia Vaccines Picture
Figure 2. Global Hemorrhagic Septicemia Vaccines Revenue Market Share by Type in 2021
Figure 3. Oil–adjuvant Vaccines
Figure 4. Aluminum hydroxide-adjuvant Vaccines
Figure 5. Global Hemorrhagic Septicemia Vaccines Revenue Market Share by Application in 2021
Figure 6. Cattle
Figure 7. Buffaloes
Figure 8. Global Hemorrhagic Septicemia Vaccines Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 9. Global Hemorrhagic Septicemia Vaccines Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Hemorrhagic Septicemia Vaccines Sales (2017-2028) & (K Units)
Figure 11. Global Hemorrhagic Septicemia Vaccines Price (2017-2028) & (USD/Unit)
Figure 12. Global Hemorrhagic Septicemia Vaccines Production Capacity (2017-2028) & (K Units)
Figure 13. Global Hemorrhagic Septicemia Vaccines Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Hemorrhagic Septicemia Vaccines Market Drivers
Figure 15. Hemorrhagic Septicemia Vaccines Market Restraints
Figure 16. Hemorrhagic Septicemia Vaccines Market Trends
Figure 17. Global Hemorrhagic Septicemia Vaccines Sales Market Share by Manufacturer in 2021
Figure 18. Global Hemorrhagic Septicemia Vaccines Revenue Market Share by Manufacturer in 2021
Figure 19. Hemorrhagic Septicemia Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Hemorrhagic Septicemia Vaccines Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Hemorrhagic Septicemia Vaccines Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Hemorrhagic Septicemia Vaccines Sales Market Share by Region (2017-2028)
Figure 23. Global Hemorrhagic Septicemia Vaccines Revenue Market Share by Region (2017-2028)
Figure 24. North America Hemorrhagic Septicemia Vaccines Revenue (2017-2028) & (USD Million)
Figure 25. Europe Hemorrhagic Septicemia Vaccines Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Hemorrhagic Septicemia Vaccines Revenue (2017-2028) & (USD Million)
Figure 27. South America Hemorrhagic Septicemia Vaccines Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Hemorrhagic Septicemia Vaccines Revenue (2017-2028) & (USD Million)
Figure 29. Global Hemorrhagic Septicemia Vaccines Sales Market Share by Type (2017-2028)
Figure 30. Global Hemorrhagic Septicemia Vaccines Revenue Market Share by Type (2017-2028)
Figure 31. Global Hemorrhagic Septicemia Vaccines Price by Type (2017-2028) & (USD/Unit)
Figure 32. Global Hemorrhagic Septicemia Vaccines Sales Market Share by Application (2017-2028)
Figure 33. Global Hemorrhagic Septicemia Vaccines Revenue Market Share by Application (2017-2028)
Figure 34. Global Hemorrhagic Septicemia Vaccines Price by Application (2017-2028) & (USD/Unit)
Figure 35. North America Hemorrhagic Septicemia Vaccines Sales Market Share by Type (2017-2028)
Figure 36. North America Hemorrhagic Septicemia Vaccines Sales Market Share by Application (2017-2028)
Figure 37. North America Hemorrhagic Septicemia Vaccines Sales Market Share by Country (2017-2028)
Figure 38. North America Hemorrhagic Septicemia Vaccines Revenue Market Share by Country (2017-2028)
Figure 39. United States Hemorrhagic Septicemia Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Hemorrhagic Septicemia Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Hemorrhagic Septicemia Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Hemorrhagic Septicemia Vaccines Sales Market Share by Type (2017-2028)
Figure 43. Europe Hemorrhagic Septicemia Vaccines Sales Market Share by Application (2017-2028)
Figure 44. Europe Hemorrhagic Septicemia Vaccines Sales Market Share by Country (2017-2028)
Figure 45. Europe Hemorrhagic Septicemia Vaccines Revenue Market Share by Country (2017-2028)
Figure 46. Germany Hemorrhagic Septicemia Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Hemorrhagic Septicemia Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Hemorrhagic Septicemia Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Hemorrhagic Septicemia Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Hemorrhagic Septicemia Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Hemorrhagic Septicemia Vaccines Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Hemorrhagic Septicemia Vaccines Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Hemorrhagic Septicemia Vaccines Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Hemorrhagic Septicemia Vaccines Revenue Market Share by Region (2017-2028)
Figure 55. China Hemorrhagic Septicemia Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Hemorrhagic Septicemia Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Hemorrhagic Septicemia Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Hemorrhagic Septicemia Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Hemorrhagic Septicemia Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Hemorrhagic Septicemia Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Hemorrhagic Septicemia Vaccines Sales Market Share by Type (2017-2028)
Figure 62. South America Hemorrhagic Septicemia Vaccines Sales Market Share by Application (2017-2028)
Figure 63. South America Hemorrhagic Septicemia Vaccines Sales Market Share by Country (2017-2028)
Figure 64. South America Hemorrhagic Septicemia Vaccines Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Hemorrhagic Septicemia Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Hemorrhagic Septicemia Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Hemorrhagic Septicemia Vaccines Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Hemorrhagic Septicemia Vaccines Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Hemorrhagic Septicemia Vaccines Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Hemorrhagic Septicemia Vaccines Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Hemorrhagic Septicemia Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Hemorrhagic Septicemia Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Hemorrhagic Septicemia Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Hemorrhagic Septicemia Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Hemorrhagic Septicemia Vaccines in 2021
Figure 76. Manufacturing Process Analysis of Hemorrhagic Septicemia Vaccines
Figure 77. Hemorrhagic Septicemia Vaccines Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source